Sagimet Biosciences (SGMT) Payables (2023 - 2024)
Sagimet Biosciences has reported Payables over the past 2 years, most recently at $1.2 million for Q3 2024.
- Quarterly results put Payables at $1.2 million for Q3 2024, down 32.31% from a year ago — trailing twelve months through Sep 2024 was $1.2 million (down 32.31% YoY), and the annual figure for FY2023 was $186000.0, changed.
- Payables for Q3 2024 was $1.2 million at Sagimet Biosciences, down from $2.0 million in the prior quarter.
- Over the last five years, Payables for SGMT hit a ceiling of $2.7 million in Q2 2023 and a floor of $186000.0 in Q4 2023.